BRIEF-Titan Pharma receives FDA communication on ropinirole implant INDA
* Titan Pharmaceuticals receives FDA communication on ropinirole implant investigational new drug application
Dec 13 Macro Enterprises Inc :
* Macro Enterprises - normal course issuer bid for up to 1.5 million common shares of co
* Macro Enterprises Inc to renew normal course issuer bid Source text for Eikon: Further company coverage:
* TSX closes down 69.96 points, or 0.45 percent, at 15,463.51
Feb 27 Travel website operator Priceline Group Inc reported a 17.4 percent rise in fourth-quarter revenue, driven by higher hotel bookings.